Skip to Main Content

LVV

Animal-origin-free proteins for every step of LVV manufacturing.

From producer cell expansion to cryopreservation, recombinant albumin, transferrin, and insulin-transferrin supplements replace serum and plasma-derived albumin, lowering variability and vector loss from harvest to storage.

Where InVitria proteins fit in LVV Manufacturing

Lentiviral vector production depends on added protein twice: to supply iron and growth signals to HEK293T producer cells through expansion and transfection, and to protect dilute, enveloped particles from adsorption, shear and freeze-thaw loss downstream. Fetal bovine serum, serum-derived transferrin and human serum albumin supply those functions, and bring human- and animal-derived material into the process. Defined, animal-origin-free recombinant proteins and supplements supply the same functions, step by step.

Where our products fit

The LVV workflow, step by step.

Select a step to see where InVitria products fit.

Producer Cell Expansion

Expand HEK293T producer cells to transfection-ready density and viability, with defined, animal-origin-free supplements supporting consistent, serum-free growth.

Overview

Producer cell expansion grows the HEK293 or HEK293T cell population used for lentiviral vector production up from a seed train to the density, passage number, and viability required for transfection. Cells are expanded in adherent or suspension-adapted culture in serum-free or chemically defined medium.

Sustained proliferation places a steady metabolic demand on cells: DNA synthesis and mitochondrial respiration require iron, and growth signaling ordinarily supported by serum must come from defined additives instead. Media are commonly supplemented with insulin, transferrin, selenium, ethanolamine, and albumin to replace serum’s function.

Defined, animal-origin-free versions of these components support predictable growth kinetics and keep the cell substrate free of human- and animal-derived material before plasmid DNA is introduced at transfection.

Functions

Cell Expansion Support

HEK293T cells expanded in serum-free medium lose the growth factors, iron carrier protein, and albumin that serum otherwise supplies. Insulin supports glucose uptake and anabolic metabolism, transferrin delivers iron for DNA synthesis and mitochondrial function, selenium supports antioxidant enzyme activity, ethanolamine supports membrane phospholipid synthesis, and albumin buffers cells against handling stress. Combined in one addition, these five components support the proliferation rate needed to reach transfection-ready density on schedule.

Recommendation
ITSE+A Animal-Free®

Five-component 100x supplement of recombinant insulin, recombinant human transferrin, selenium, ethanolamine, and recombinant human albumin for serum-free cell culture.

Commonly replaces
Fetal bovine serum (FBS) supplementation in producer cell expansion medium.

Iron Transport

Proliferating producer cells have a high iron requirement to support DNA synthesis, mitochondrial respiration, and ribonucleotide reductase activity. Serum-free medium contains no serum-derived transferrin to deliver iron by receptor-mediated endocytosis. Without a protein-bound iron carrier, cells depend on free iron, which is poorly taken up and can generate reactive oxygen species, constraining growth rate through the expansion phase before transfection.

Recommendation
Optiferrin®

Recombinant human transferrin, lyophilized, for iron delivery in serum-free and chemically defined media.

Commonly replaces
Serum-derived transferrin or synthetic iron chelators in serum-free expansion medium.

Transfection / Plasmid Delivery

Introduce gag-pol, rev, envelope, and transfer plasmids into producer cells, with defined albumin and transferrin supporting cell health through transfection stress.

Overview

Transfection introduces the plasmids that direct lentiviral vector assembly into producer cells: typically separate plasmids encoding gag-pol, rev, a pseudotyping envelope such as VSV-G, and the transfer vector carrying the gene of interest between long terminal repeats. Plasmid DNA is complexed with a cationic reagent, commonly polyethylenimine (PEI), and added to the culture.

Transfection reagent-DNA complexes are cytotoxic in a dose-dependent manner, and the process transiently increases membrane permeability and osmotic load on the cell. Producer cells are also entering a period of high biosynthetic demand, assembling viral proteins and packaging vector RNA, which increases their requirement for iron.

Defined transferrin and albumin support cells through this stress, sustaining the iron supply proliferation and vector assembly require while buffering cells against the added chemical burden, in animal-origin-free form.

Functions

Transfection Complex Stabilization

PEI-DNA complexes are cytotoxic in a dose-dependent manner, and transfection transiently increases plasma membrane permeability and osmotic stress. A protein in the medium buffers cells against this chemical and osmotic burden and limits nonspecific adsorption of transfection reagent and DNA complexes to culture surfaces, supporting producer cell viability through the transfection window so that a larger fraction of cells survive to produce vector.

Recommendation
Optibumin® X

High-purity, 25% recombinant human serum albumin with an ultra-low fatty acid profile for stem cell (iPSC/MSC/etc.) and lipid-sensitive applications, supplied in saline with no added stabilizers.

Commonly replaces
Human serum albumin (HSA) or serum supplementation during transfection.

Vector Production & Harvest

Support producer cells through vector assembly and budding, with defined albumin and transferrin protecting cell health and vector particles through harvest.

Overview

During vector production, transfected cells express gag-pol, rev, envelope, and transfer vector RNA, assembling lentiviral particles that bud from the plasma membrane into the culture supernatant. Producer cells are cultured for one to several days post-transfection, and vector-containing supernatant is collected, often across multiple harvests as budding continues.

Vector particles are enveloped and shear-sensitive, and the lipid envelope can be disrupted by surface interactions and mechanical stress during collection. Producer cells, already stressed by transfection, continue to require iron and protection from further handling stress through the harvest window.

Defined albumin protects budded vector particles and stressed producer cells during collection, while defined transferrin continues supporting cell metabolic function, both in animal-origin-free form through this production phase.

Functions

Cell & Vector Support

Producer cells remain stressed from transfection while assembling and budding vector particles, and the budded, enveloped lentiviral particles themselves are shear-sensitive and prone to nonspecific adsorption onto culture-vessel and harvest-line surfaces. A protein in the supernatant buffers cells against continued handling stress and limits vector loss to surfaces during collection, supporting both cell viability and vector recovery through harvest.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Human serum albumin (HSA) or serum supplementation during production culture.

Iron Transport

Producer cells continue synthesizing viral structural proteins and packaging vector RNA throughout the production window, sustaining a high iron requirement for DNA replication and mitochondrial respiration. Serum-free supernatant carries no serum-derived transferrin, and cells that lose access to protein-bound iron transport lose viability and vector output as production continues.

Recommendation
Optiferrin®

Recombinant human transferrin, lyophilized, for iron delivery in serum-free and chemically defined media.

Commonly replaces
Serum-derived transferrin in production-phase culture medium.

Clarification

Clarify harvested supernatant by filtration or centrifugation, with defined albumin limiting vector loss to filter and surface adsorption.

Overview

Clarification removes producer cells, cell debris, and aggregates from harvested vector supernatant, typically by low-speed centrifugation followed by depth filtration, or by depth filtration alone in fully closed processes. The goal is to protect downstream chromatography and filtration steps from fouling while retaining as much infectious vector as possible.

Lentiviral particles are enveloped and present at relatively low concentration in crude supernatant, and they adsorb nonspecifically to filter membranes, tubing, and vessel surfaces, particularly at the low-protein-concentration, low-particle-density conditions typical of clarified harvest.

A defined, animal-origin-free protein in the clarification pool competes for these binding sites, limiting vector loss to surfaces and helping preserve titer as material moves into nuclease treatment and purification.

Functions

Anti-Adsorption

Enveloped lentiviral particles are present at low concentration in clarified supernatant and adsorb nonspecifically to depth filter media, tubing, and vessel surfaces, a loss mechanism that becomes proportionally larger as particle concentration drops. A carrier protein in the pool occupies available binding surface, limiting particle-to-surface adsorption and helping preserve infectious titer as material passes through clarification.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Human serum albumin (HSA) or serum-based blocking agents in clarification buffers.

Nuclease Treatment

Treat clarified harvest with an endonuclease to digest residual plasmid and host-cell nucleic acid ahead of purification.

Overview

Nuclease treatment digests residual plasmid DNA and host-cell genomic DNA and RNA that remain in clarified lentiviral vector harvest. An endonuclease, most commonly Benzonase, is added directly to the clarified pool and incubated under controlled temperature, pH, and time, often with divalent cation (typically magnesium) supplementation the enzyme requires for activity.

Benzonase nonspecifically cleaves double- and single-stranded DNA and RNA into short oligonucleotide fragments, reducing residual nucleic acid to the low levels regulatory guidance requires per dose and reducing the viscosity that high-molecular-weight host-cell DNA otherwise imparts to the pool.

Digestion is typically confirmed by residual DNA assay (such as qPCR against the packaging cell genome) before the pool proceeds to purification. Reduced viscosity and DNA content also improve the performance of downstream chromatography and filtration steps.

Capture & Polish Chromatography (AEX ± SEC)

Purify vector from host-cell protein, DNA, and process contaminants by chromatography, with defined albumin limiting vector loss to resin and system surfaces.

Overview

Purification separates lentiviral vector particles from host-cell protein, residual DNA fragments, plasmid remnants, and other process-related impurities. Common approaches include anion-exchange or membrane chromatography, and affinity methods where a suitable ligand is available for the envelope glycoprotein; tangential flow filtration (TFF) is often used alongside chromatography for volume reduction and buffer exchange between steps.

As with clarification, vector particles at this stage are still present at relatively low concentration and are enveloped, making them susceptible to loss through nonspecific adsorption to chromatography resin, membranes, and flow-path surfaces, as well as to shear during pumping and filtration.

A defined, animal-origin-free protein added to purification buffers limits this surface loss, supporting recovery through chromatography and TFF as the pool is prepared for concentration and formulation.

Concentration & Buffer Exchange (TFF / UF-DF)

Concentrate vector by TFF and exchange into final buffer, with defined albumin protecting particles against membrane shear and surface loss.

Overview

Concentration and buffer exchange reduce the purified vector pool to final process volume and exchange it into the buffer used for formulation, typically by tangential flow filtration against a membrane with a molecular weight cutoff well below the size of an intact lentiviral particle.

TFF exposes vector particles to recirculation shear and to the filtration membrane surface over an extended processing time, and the enveloped particle is sensitive to both. Diafiltration also transiently changes the ionic and osmotic environment around the particle as buffer is exchanged.

A defined, animal-origin-free protein in the retentate buffers particles against membrane shear and limits adsorptive loss to the membrane surface, supporting titer recovery into the buffer used for fill and formulation.

Functions

Vector Protection

Tangential flow filtration exposes vector particles to sustained recirculation shear and extended contact with the filtration membrane surface, both of which threaten the integrity of the lipid envelope and drive nonspecific particle adsorption to the membrane. A carrier protein in the retentate buffers particles against this shear and competes for membrane binding sites, supporting titer recovery as the pool is concentrated and exchanged into formulation buffer.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Human serum albumin (HSA) supplemented into TFF retentate and diafiltration buffers.

Sterile / Bioburden Filtration

0.22 um bioburden-reduction filtration ahead of fill. For enveloped, shear-sensitive vectors this is a high-loss step; recombinant albumin protects titer.

Overview

Enveloped, shear- and adsorption-sensitive vectors (lentiviral, gamma-retroviral) lose significant titer on sterilizing-grade membranes. A 0.22 um filtration is performed before or at formulation; pre-coating the membrane with recombinant albumin and including it in the buffer passivates the membrane and buffers the vector against shear and aggregation, preserving infectious and genomic titer.

Functions

Filtration Titer Protection

Sterilizing filtration is typically the single highest-loss operation for enveloped vectors; a passivating protein on the membrane and in the buffer limits vector adsorption, shear, and aggregation loss.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Plasma-derived HSA used as a filtration/stabilization additive.

Sterile Fill & Formulation

Formulate concentrated vector and sterile-filter into final containers, with defined albumin stabilizing particles against freeze-thaw and surface loss.

Overview

Sterile fill and formulation prepares the concentrated, buffer-exchanged vector pool for final containers. The pool is formulated with excipients that protect particle integrity through freezing and storage, sterile-filtered (commonly 0.22 micron), and filled into vials or bags under aseptic conditions.

Formulation is the last opportunity to protect the particle before it is frozen: lentiviral vector is enveloped and freeze-thaw sensitive, and dilute vector is prone to aggregation and adsorptive loss to container and closure surfaces during fill.

A defined, animal-origin-free stabilizing excipient in the formulation buffer limits this loss and supports vector recovery through freezing, in liquid or, where a dry formulation workflow is used, lyophilized form.

Functions

Formulation Stabilization

Formulated vector is dilute relative to production-scale concentrations and enveloped, making it susceptible to aggregation and to adsorptive loss on container, closure, and fill-line surfaces during sterile filtration and filling. A stabilizing excipient occupies these surfaces and buffers particles against the freeze-thaw stress that follows fill, supporting recovered infectious titer at the point of use.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Human serum albumin (HSA) as a stabilizing excipient in viral vector formulation buffers.

Cryopreservation & Storage

Cryopreserve filled vector for long-term storage, with defined albumin protecting particles against freeze-thaw and container-surface loss.

Overview

Cryopreservation and storage hold finished lentiviral vector at low temperature, typically -80°C or below, to maintain infectious titer between fill and use. Filled containers are frozen under controlled conditions and held in qualified freezer or vapor-phase nitrogen storage.

Freezing and thawing subject enveloped vector particles to ice-crystal formation, osmotic shifts, and mechanical stress, and dilute vector remains susceptible to adsorptive loss on vial or bag surfaces throughout storage. Repeated freeze-thaw cycling compounds this loss.

A defined, animal-origin-free stabilizing excipient carried through from formulation continues protecting the particle during freezing, storage, and thaw, supporting infectious titer at the point the vector is used.

Functions

Storage Stabilization

Freezing exposes vector particles to ice-crystal formation and osmotic shifts, and thaw repeats that stress in reverse; dilute, enveloped vector is also prone to continued adsorptive loss on container surfaces across a storage hold. A stabilizing excipient carried through from formulation buffers particles against this cycle, limiting loss of infectious titer between fill and administration.

Recommendation
Optibumin® 25

Approved excipient 25% recombinant human serum albumin, supplied in bottles and closed-system friendly bags for processing, formulation, cryopreservation, and advanced biomanufacturing.

Commonly replaces
Human serum albumin (HSA) as a cryoprotective excipient in viral vector storage formulations.